feed,title,long_url,short_url
SeekingAlpha,Actinium concludes planned Phase 1 Actimab-A CLAG-M combination trial,https://seekingalpha.com/news/3613761,
SeekingAlpha,"VXRT, IMMU, GRPN and CODX among midday movers",https://seekingalpha.com/news/3613760,
